ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Whitehawk Therapeutics, Inc.
1.40
-0.1100
-7.28%
成交量:
2.85萬
成交額:
4.13萬
市值:
6,549.85萬
市盈率:
-0.59
高:
1.50
開:
1.50
低:
1.39
收:
1.51
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
Whitehawk Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2007
員工人數:
40
公司地址:
2 Headquarters Plaza,East Building,11th Floor,Morristown,New Jersey,United States
官網:
http://www.whitehawktx.com
郵編:
07960
電話:
551 321 2234
傳真:
- -
簡介:
Whitehawk Therapeutics, Inc.於2007年11月16日在特拉華州成立。該公司是一家臨床階段的生物製藥公司,為基因定義的癌症開發精準療法。該公司的主要目標是為mTOR通路驅動因子變化的癌症患者帶來轉化療法,例如TSC1或TSC2基因的變化,而mTOR抑製劑由於藥理學、有效藥物遞送、安全性或有效性問題而沒有或不能得到有效利用。Aadi的主要產品是FYARROTM,這是一種mTOR抑製劑,可與人類蛋白質結合,並显示出更高的腫瘤積累、更大的mTOR靶點抑制和增強的腫瘤生長抑制。
董事
名稱
職位
Joseph Gardner
President, Principal Executive Officer and Director
Anupam Dalal
Director
Caley Castelein
Director
Cheryl Cohen
Director
Pravin U. Dugel
Director
Steven Prelack
Director
股東
名稱
職位
Joseph Gardner
President, Principal Executive Officer and Director
Kevin G. Peters
Chief Scientific Officer and acting Chief Medical Officer
Regina Marek
Vice President, Principal Financial and Accounting Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/WHWK/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WHWK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","market":"US","secType":"STK","nameCN":"Whitehawk Therapeutics, Inc.","latestPrice":1.4,"timestamp":1745603770810,"preClose":1.51,"halted":0,"volume":28529,"delay":0,"floatShares":29262500,"shares":46784618,"eps":-2.356312,"marketStatus":"交易中","change":-0.11,"latestTime":"04-25 13:58:24 EDT","open":1.5,"high":1.5,"low":1.39,"amount":41279.0922401,"amplitude":0.072848,"askPrice":1.41,"askSize":233,"bidPrice":1.39,"bidSize":105,"shortable":3,"etf":0,"ttmEps":-2.356312,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1745611200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.51,"preHourTrading":{"tag":"盘前","latestPrice":1.5,"preClose":1.51,"latestTime":"09:06 EDT","volume":50,"amount":75,"timestamp":1745586399499},"postHourTrading":{"tag":"盘后","latestPrice":1.4834,"preClose":1.51,"latestTime":"19:00 EDT","volume":706,"amount":1049.302,"timestamp":1745535655808},"volumeRatio":0.978175,"impliedVol":2.0497,"impliedVolPercentile":0.8148},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","floatShares":29262500,"roa":"-39.96%","roe":"-80.79%","lyrEps":-2.356312,"volumeRatio":0.978175,"shares":46784618,"dividePrice":0,"high":1.5,"amplitude":0.072848,"preClose":1.51,"low":1.39,"week52Low":1.21,"pbRate":"1.25","psRate":"2.52","week52High":3.812,"institutionHeld":0,"latestPrice":1.4,"committee":-0.378698,"eps":-2.356312,"divideRate":0,"volume":28529,"delay":0,"ttmEps":-2.356312,"open":1.5,"prevYearClose":3.155,"prevWeekClose":1.57,"prevMonthClose":1.78,"prevQuarterClose":1.78,"fiveDayClose":1.57,"twentyDayClose":1.9,"sixtyDayClose":2.89},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":430225247,"yearFounded":2007,"employeeNum":40,"address":"2 Headquarters Plaza,East Building,11th Floor,Morristown,New Jersey,United States","zipCode":"07960","officePhone":"551 321 2234"},"stockCompanyDetail":{"websiteUrl":"http://www.whitehawktx.com","stockEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.2256},{"period":"3month","weight":-0.5191},{"period":"6month","weight":-0.2488},{"period":"1year","weight":-0.1517},{"period":"ytd","weight":-0.5214}],"compareEarnings":[{"period":"1week","weight":0.0385},{"period":"1month","weight":-0.05},{"period":"3month","weight":-0.1008},{"period":"6month","weight":-0.0559},{"period":"1year","weight":0.0817},{"period":"ytd","weight":-0.0672}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Whitehawk Therapeutics, Inc.於2007年11月16日在特拉華州成立。該公司是一家臨床階段的生物製藥公司,為基因定義的癌症開發精準療法。該公司的主要目標是為mTOR通路驅動因子變化的癌症患者帶來轉化療法,例如TSC1或TSC2基因的變化,而mTOR抑製劑由於藥理學、有效藥物遞送、安全性或有效性問題而沒有或不能得到有效利用。Aadi的主要產品是FYARROTM,這是一種mTOR抑製劑,可與人類蛋白質結合,並显示出更高的腫瘤積累、更大的mTOR靶點抑制和增強的腫瘤生長抑制。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.179486},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.0383},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.227585},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.01593},{"month":5,"riseRate":0.833333,"avgChangeRate":0.198965},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.098715},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.019883},{"month":8,"riseRate":0.571429,"avgChangeRate":0.031928},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.003937},{"month":10,"riseRate":0,"avgChangeRate":-0.14358},{"month":11,"riseRate":0.714286,"avgChangeRate":0.092547},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.101414}],"exchange":"NASDAQ","name":"Whitehawk Therapeutics, Inc.","nameEN":"Whitehawk Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"WHWK\",market:\"US\",,,undefined,":{"directors":[{"name":"Joseph Gardner","position":"President, Principal Executive Officer and Director"},{"name":"Anupam Dalal","position":"Director"},{"name":"Caley Castelein","position":"Director"},{"name":"Cheryl Cohen","position":"Director"},{"name":"Pravin U. Dugel","position":"Director"},{"name":"Steven Prelack","position":"Director"}],"executives":[{"name":"Joseph Gardner","position":"President, Principal Executive Officer and Director"},{"name":"Kevin G. Peters","position":"Chief Scientific Officer and acting Chief Medical Officer"},{"name":"Regina Marek","position":"Vice President, Principal Financial and Accounting Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WHWK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-19","symbol":"WHWK","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"盤前","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"WHWK","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"盤前","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2024-08-07","symbol":"WHWK","fiscalQuarterEnding":"2024/06","expectedEps":-0.71,"name":null,"time":"盤前","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2024-05-08","symbol":"WHWK","fiscalQuarterEnding":"2024/03","expectedEps":-0.66,"name":null,"time":"盤前","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-03-13","symbol":"WHWK","fiscalQuarterEnding":"2023/12","expectedEps":-0.67,"name":null,"time":"盤前","type":"earning","dateTimestamp":1710302400000,"reportTimeType":"pre","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WHWK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WHWK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1744776000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/WHWK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"WHWK","date":"2025-04-24","current":-1.131217,"percent":0.541667,"low":-1.256091,"twenty":-1.213487,"median":-1.138562,"eighty":-0.757714,"high":-0.688831,"avg":-1.033481,"sd":0.215284,"marketCap":72048311},"quantilePoints":[{"date":"2025-03-21","current":-0.758488,"twenty":-0.777063,"median":-0.770098,"eighty":-0.763132,"marketCap":48308888},{"date":"2025-03-28","current":-0.735269,"twenty":-0.778611,"median":-0.758488,"eighty":-0.745331,"marketCap":46830044},{"date":"2025-04-04","current":-1.204672,"twenty":-1.122401,"median":-0.762358,"eighty":-0.739913,"marketCap":76726773},{"date":"2025-04-11","current":-1.189981,"twenty":-1.212018,"median":-0.793317,"eighty":-0.745331,"marketCap":75791081},{"date":"2025-04-17","current":-1.131217,"twenty":-1.219363,"median":-1.160599,"eighty":-0.754619,"marketCap":72048311},{"date":"2025-04-24","current":-1.131217,"twenty":-1.213487,"median":-1.138562,"eighty":-0.757714,"marketCap":72048311}],"updateTime":1745603039977}}}